Circulating α-Klotho Levels in Relation to Cardiovascular Diseases: A Mendelian Randomization Study

Xingang Sun1, Lu Chen1, Yuxian He1

  • 1Department of Cardiology and Atrial Fibrillation Center of The First Affiliated Hospital of Zhejiang University, Hangzhou, China.

Frontiers in Endocrinology
|February 24, 2022
PubMed

Insights

Genetically predicted higher levels of circulating alpha-Klotho show a protective effect against atrial fibrillation (AF). However, this study found no causal link between alpha-Klotho and coronary artery disease (CAD) or stroke risk.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Biomarkers

Background:

  • Circulating α-Klotho's protective role in cardiovascular diseases (CVD) is suggested but lacks causal evidence.
  • Investigating the causal relationship between genetically predicted α-Klotho and major CVDs is crucial.

Purpose of the Study:

  • To determine if genetically predicted circulating α-Klotho levels are causally associated with the risk of coronary artery disease (CAD), atrial fibrillation (AF), heart failure (HF), and stroke.
  • To elucidate the causal link between α-Klotho and ischemic stroke (IS) and its subtypes.

Main Methods:

  • A two-sample Mendelian randomization (MR) study utilized 5 single-nucleotide polymorphisms for genetically predicted α-Klotho.
  • Fixed-effects inverse-variance weighted (IVW) and meta-analysis combined estimates from multiple data sources.
  • Sensitivity analyses included simple median, weighted median, MR-Egger, and MR-pleiotropy residual sum and outlier (MR-PRESSO).

Main Results:

  • A suggestive inverse causal association was found between α-Klotho and CAD (OR, 0.97; P=0.044).
  • A significant inverse association was observed between α-Klotho and AF (OR, 0.96; P=0.005).
  • No causal associations were detected for HF, any stroke, IS, or IS subtypes.

Conclusions:

  • Genetically predicted circulating α-Klotho has a protective effect on preventing atrial fibrillation (AF) risk.
  • No significant causal association was found between genetically predicted α-Klotho levels and the risk of CAD, HF, stroke, IS, or IS subtypes.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
247
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
383
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
315
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
56
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
70